It has been shown that the expression of the FCN3 gene is lower in the case of different cancers [250], and a recent study demonstrated that hepatocellular carcinoma patients with a high FCN3 expression had a significantly better overall survival [251]. This evidence concerns the gene FCN3 and cancer.